Letter to the editor: Glomerular endothelial dysfunction in type 2 diabetes mellitus [1]

Renal Failure

Volumn 28, Issue 6, 2006, Pages 523-524

  Futrakul, Narisa ^a   Butthep, Punnee ^b   Futrakul, Prasit ^a   Sittipreja, Visith ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Circulating endothelial cell; FE Mg; Glomerular endothelial dysfunction; Hemodynamics; Vasodilators

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; ENALAPRIL; ISRADIPINE; TELMISARTAN; VASODILATOR AGENT;

DIABETIC NEPHROPATHY; ENDOTHELIAL DYSFUNCTION; GLOMERULOPATHY; GLOMERULUS ENDOTHELIUM DYSFUNCTION; HEMODYNAMICS; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; VASODILATATION; DIABETIC ANGIOPATHY; GLOMERULUS; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; HUMANS; KIDNEY GLOMERULUS; VASODILATOR AGENTS;

EID: 33747794943     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600767293     Document Type: Letter

References (2)

1. Futrakul P, Yenrudi S, Futrakul N, Sensirivatana R, Kingwatanakul P, Jungthirapanich J, et al. Tubular function and tubulointerstitial disease. Am. J. Kidney Dis. 1999;33:886-891.
2. Hidgers KF, Veelken R. Type 2 diabetic nephropathy: never too early to treat? J. Am. Soc. Nephrol. 2005;16:574-575.